SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001787306-23-000086
Filing Date
2023-09-05
Accepted
2023-09-05 21:36:53
Documents
2
Period of Report
2023-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1693964204.html 3  
1 FORM 3 wk-form3_1693964204.xml 3 8089
2 EX-24 johnsmitherpoa1.htm EX-24 8654
  Complete submission text file 0001787306-23-000086.txt   18270
Mailing Address C/O KYTHERA BIOPHARMACEUTICALS, INC. 27200 WEST AGOURA ROAD, SUITE 200 CALABASAS CA 91301
Business Address
Smither John W (Reporting) CIK: 0001559583 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39186 | Film No.: 231237661

Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Issuer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations